Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL21224201

CSCCC(N)C(=O)Nc1nc(-c2ccccc2)cs1.O=C(O)C(F)(F)F

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 5/20 0.57
HDAC3 O15379 4/20 0.50
HDAC4 P56524 4/20 0.50
HDAC1 Q13547 4/20 0.50
HDAC7 Q8WUI4 4/20 0.50
HDAC2 Q92769 4/20 0.50
HDAC10 Q969S8 4/20 0.50
HDAC11 Q96DB2 4/20 0.50
HDAC8 Q9BY41 4/20 0.50
HDAC9 Q9UKV0 4/20 0.50
HDAC5 Q9UQL6 4/20 0.50
MAPT P10636 4/20 0.47
ELOVL1 Q9BW60 1/20 0.47
MRE11 P49959 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
GAA P10253 1/20 0.46
NPC1 O15118 1/20 0.46
CASP3 P42574 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL21224199 1.00 HDAC6 (0.57) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL21224715 0.94 HDAC6 (0.63) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL21224560 0.94 HDAC6 (0.63) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL22970146 0.88 HDAC6 (0.67) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL22305385 0.82 MAPT (0.54) HDAC6MAPTELOVL1MEN1KMT2A
SCHEMBL21224492 0.82 HDAC6 (0.67) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL21224494 0.82 HDAC6 (0.67) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL30657979 0.81 HDAC6 (0.49) HDAC6HDAC4MRE11
SCHEMBL23704796 0.81 KDM4E (0.54) HDAC6MAPTMRE11MEN1KMT2A
SCHEMBL23704797 0.81 KDM4E (0.54) HDAC6MAPTMRE11MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230138480-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-04 US disclosed
US-20210038611-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2021-02-11 US disclosed
CN-112153984-A Compound and use thereof 福宏治疗公司 2020-12-29 CN disclosed
EP-3746124-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2020-12-09 EP disclosed
WO-2019152437-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2019-08-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230138480-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB HDAC6 86/4885HDAC3 231/4885HDAC4 152/4885
US-20210038611-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB HDAC6 86/4885HDAC3 231/4885HDAC4 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.